Repeat biopsies in patients with TNBC may detect changes in HER2 status and allow more patients to gain access to T-DXd, data suggest.

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present 18 abstracts, ...

Overall, the one-time LDCT diagnostic performance in the non-risk-based screening population had a sensitivity of 96.6%, a ...

Somewhere in the body of a patient, a small clump of cells, growing undetected, has begun to form a tumor. It has yet to cause pain or visible symptoms of illness. Several months from now, or perhaps ...

Life with a rare lung disease has been challenging for Diana and her family, but her determination to stay healthy has ...

Saint Francis Hospital is the first in the state to complete 1,000 robotic-assisted bronchoscopy procedures with the Ion ...

Background Muscle wasting and weakness (sarcopenia) are commonly associated with COPD causing frailty and reduced quality of ...

Women are frequently advised to schedule their annual mammograms and men a blood test for PSA to screen for prostate cancer. The list of adult screenings also includes a colonoscopy ...

Dr Ahmed Fahim discusses the UK Idiopathic Pulmonary Fibrosis Registry and how its findings enhance understanding and ...

The Ion Robotic Bronchoscopy System, a revolutionary tool in the field of pulmonary care, allows physicians to locate and ...